PM360 Article (May 2012) – Insurer Suits Highlight Copay Assistance
Article in PM360online.com – Insurer Suits Highlight Copay Assistance
By Andrew Matthius
In March, several health plans in Community Catalyst’s Prescription Access Litigation coalition filed class action lawsuits that claimed copay coupons were illegal bribes made by drug manufacturers to patients. The lawsuits were filed by the AFSCME District Council 37 Health & Security Plan Trust, Sergeants Benevolent Association, the New England Carpenters, and the Plumbers and Pipefitters Local 572 Health and Welfare Fund in four federal courts (New York, Chicago, Philadelphia and Newark), against nine drug manufacturers (Abbott, Amgen, AstraZeneca, Bristol-Meyers-Squibb, GlaxoSmithKline, Merck, Novartis, Otsuka America Pharmaceutical, and Pfizer), and cited 25 brand-name drugs (including Lipitor, Nexium, Crestor, Diovan, Enbrel, Humira, Abilify, Nasonex, Vytorin, and Lovaza).
The Amundsen Group
The Amundsen Group brings a team of seasoned consultants and new approaches that are at the forefront of today’s pharmaceutical sales and marketing environment and can help you navigate the daunting challenges that lie ahead.
January 25, 2013
September 20, 2012
May 8, 2012
January 17, 2012